Z-2736-2024 Class II Ongoing

Recalled by Abbott Diagnostics Technologies AS — Oslo

FDA device recall Z-2736-2024 was initiated by Abbott Diagnostics Technologies AS on Jun 17, 2024 and is designated Class II. Reason for recall: Five Afinion 2 (AF2) Analyzer were incorrectly market configured as Moderate Complexity and distributed to customers. Use of moderately complex assays by waived laboratories could result in erroneous… The recall status is ongoing. Affected quantity: 5 analyzers.

Recall details

Product Type
Devices
Report Date
Sep 4, 2024
Initiation Date
Jun 17, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 analyzers

Product description

Afinion 2 Analyzer, model #1116986, US refurbished, CLIA waived.

Reason for recall

Five Afinion 2 (AF2) Analyzer were incorrectly market configured as Moderate Complexity and distributed to customers. Use of moderately complex assays by waived laboratories could result in erroneous results.

Distribution pattern

US Nationwide distribution in the states of AZ, IN, MA, MN, and OH.

Code information

Lot #433706, Serial numbers AF20008880, AF20002691, AF20035414, AF20015543 and AF20035460; UDI-DI: 07070060014708.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2736-2024
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Abbott Diagnostics Technologies AS? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-2736-2024. Report a data issue: hello@regdatalab.com.